Humacyte Stock Overlap Studies Triple Exponential Moving Average

HUMA Stock  USD 4.49  0.11  2.51%   
Humacyte overlap studies tool provides the execution environment for running the Triple Exponential Moving Average study and other technical functions against Humacyte. Humacyte value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Triple Exponential Moving Average study function is designed to identify and follow existing trends. Humacyte overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was six with a total number of output elements of fifty-five. Humacyte Triple Exponential Moving Average indicator shows smoothing effect of Humacyte price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Humacyte Technical Analysis Modules

Most technical analysis of Humacyte help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Humacyte from various momentum indicators to cycle indicators. When you analyze Humacyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Humacyte Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Humacyte. We use our internally-developed statistical techniques to arrive at the intrinsic value of Humacyte based on widely used predictive technical indicators. In general, we focus on analyzing Humacyte Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Humacyte's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Humacyte's intrinsic value. In addition to deriving basic predictive indicators for Humacyte, we also check how macroeconomic factors affect Humacyte price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Graham Number8.043.991.781.69
Receivables Turnover7.1850.4845.4447.71
Hype
Prediction
LowEstimatedHigh
0.224.339.40
Details
Intrinsic
Valuation
LowRealHigh
0.675.7410.81
Details
Naive
Forecast
LowNextHigh
0.083.979.05
Details
7 Analysts
Consensus
LowTargetHigh
6.757.428.24
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Humacyte in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Humacyte's short interest history, or implied volatility extrapolated from Humacyte options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Momentum Idea
Momentum
Invested over 60 shares
Impulse Idea
Impulse
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Social Domain Idea
Social Domain
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Chemicals Idea
Chemicals
Invested over 30 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
ESG Investing Idea
ESG Investing
Invested few shares
When determining whether Humacyte is a strong investment it is important to analyze Humacyte's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Humacyte's future performance. For an informed investment choice regarding Humacyte Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Humacyte Stock refer to our How to Trade Humacyte Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Humacyte. If investors know Humacyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Humacyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.34)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.53)
Return On Equity
(8.51)
The market value of Humacyte is measured differently than its book value, which is the value of Humacyte that is recorded on the company's balance sheet. Investors also form their own opinion of Humacyte's value that differs from its market value or its book value, called intrinsic value, which is Humacyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Humacyte's market value can be influenced by many factors that don't directly affect Humacyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Humacyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humacyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humacyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.